Marvell agrees to buy Lumentum in $115 billion deal
Marvell agreed to buy Lumentum in a $115 billion all-stock deal, and both stocks fell sharply.
Objective Facts
Marvell Technology announced on November 2, 2026 that it will buy Lumentum, a maker of lasers and optical transceivers for AI data centers, in an all-stock transaction with an implied enterprise value of $115 billion. Reuters put the equity value at $102.5 billion. Lumentum shareholders will receive 4.5 Marvell shares per share, worth $1,132 at announcement and a 23.9% premium to the October 28 close, and will own about 33% of the combined company. The deal requires approval from both sets of shareholders and from regulators, and the companies expect it to close in the first half of 2028. Investors reacted badly: Marvell fell 12.7% and Lumentum dropped 18.6% on announcement day, according to TIKR. Taiwanese tech outlets such as TechNews framed the deal mainly around dilution and a possibly long Chinese regulatory review.
Deep Dive
The deal followed a week of leaks. Bloomberg reported advanced talks after the October 28 close, and Marvell shares fell more than 13% on October 29, according to TechNews in Taiwan. Both companies had ridden the AI networking boom: Yahoo Finance reported that Marvell was up more than 130% this year and Lumentum 128% before the announcement. Nvidia invested $2 billion in each company in March, TechCrunch reported, and Marvell is already a customer for Lumentum lasers. Reuters said this would be Marvell's largest purchase by far, more than ten times its $10 billion Inphi deal in 2021, and it comes months after Marvell closed its $3.5 billion Celestial AI acquisition. Marvell's case rests on owning more of the optical link between AI chips. The companies claim a combined addressable market of $550 billion, more than $1 billion in annual cost synergies and earnings accretion in the first year after closing. TrendForce said the purchase would fill gaps in Marvell's optical lineup and sharpen its rivalry with Broadcom. The skeptics have the numbers on price: Reuters calculated the deal at about 33 times Lumentum's projected core operating profit against a peer median near 16, and TradingKey cited a Morningstar view that Lumentum already traded about 22% above fair value before the rumors. Because the deal is paid in stock, Marvell's slide has already cut the offer's value well below the headline $1,132, which TIKR estimated at roughly $771 on November 2. The next tests are shareholder votes at both companies and regulatory reviews in the US and China, which TechNews said could take a long time. Reuters reported that Marvell would owe Lumentum a $3.2 billion break fee if regulators block the deal, and $5.8 billion if its board walks away or takes another offer, while Lumentum would owe $2.9 billion in similar cases. With closing targeted for the first half of 2028, the gap between Lumentum's share price and the deal value will show how much doubt investors keep pricing in.
Regional Perspective
Coverage from Taiwan, home to much of the AI hardware supply chain, began before the announcement. TechNews reported on October 30 that Marvell shares fell more than 13% on the talks and listed the risks analysts raised: a likely all-stock structure because Marvell held about $3.9 billion in cash, near-term dilution, a rich premium, and a review by regulators in both the US and China. TrendForce, a Taipei research firm, wrote on October 29 that the deal could rank among the ten largest tech and telecom deals and cited Bernstein analysts on financing and integration risk. In Israel, CTech (the tech section of Calcalist) published the Reuters story on announcement day. The main difference from US coverage is the weight given to China. US reports from TechCrunch and Yahoo Finance focused on deal size and the stock drop and did not discuss Beijing's review, while TechNews put Chinese approval near the top of its risk list. TechNews also raised a customer question US outlets mostly skipped: why Lumentum would sell when, the outlet said, its capacity is sold out through fiscal 2029. TrendForce framed the deal as a contest with Broadcom more than a bet on Nvidia. The stakes for the region come from Chinese merger review and supply chains. A long approval in China could stretch past the 2028 target, and Reuters noted a proposed US ban on new Chinese optical transceivers that could steer demand toward US suppliers such as Lumentum.